The feasibility and clinical benefits of improving facial affect recognition impairments in schizophrenia: Systematic review and meta-analysis

Bordon, Natalie; O’Rourke, Suzanne; Hutton, Paul

doi:10.1016/j.schres.2017.01.014

Cited by 47 publications

(26 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, in the FEP group, correct identification of fear was correlated with better quality of social relationships, with a possible interpretation that patients with a better ability to recognize other people's emotions have better social skills and are more satisfied with their relationships. Although we were not assessing our patients' functionality, these results could be in line with previous studies that show lower levels of social functioning in patients with poorer emotional recognition performance (Bordon, O'Rourke, & Hutton, 2017;Irani, Seligman, Kamath, Kohler, & Gur, 2012;Pinkham et al, 2007).…”

Section: Discussionsupporting

confidence: 87%

“…Second, the results also suggest that FER of anger and fear may depend on or contribute to clinical symptoms. Thus, assessment of FER should be included in the clinical assessment and treatment plan from the beginning of the illness, especially since studies have found positive results for treatment directed toward emotional processing (Bordon et al, 2017).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Differences in Facial Emotional Recognition Between Patients With the First-Episode Psychosis, Multi-episode Schizophrenia, and Healthy Controls

Kuharić¹,

Kekin

Lovrenčić

et al. 2018

J Int Neuropsychol Soc

View full text Add to dashboard Cite

Objectives: The aim of our study was to assess the differences in facial emotional recognition (FER) between patients with first-episode psychosis (FEP), patients with multi-episode schizophrenia (SCH), and healthy controls (HC) and to find possible correlations of FER with psychopathology in the two patient groups. Methods: We performed a cross-sectional study enrolling 160 patients from two psychiatric hospitals in Croatia (80 FEP and 80 SCH) and 80 HC during the period from October 2015 until October 2017. Patients were assessed once during their hospital treatment, using the Penn Emotion Recognition Task for assessment of FER, rating scales for psychopathology and depression and self-reporting questionnaires for impulsiveness, aggression, and quality of life. Results: The number of correctly identified emotions significantly decreased from HC to FEP [Δ −7%; 95% confidence interval (CI) [−12% to −3%], effect size r = 0.30] and more markedly in SCH (Δ −15%; 95% CI [−25% to −10%], effect size r = 0.59) after the adjustment for age and gender and correction for multiple testing. Correct FER for negative emotions, but not for happiness and neutral emotions, had a statistically significant negative correlation with some features on the scales of psychopathology, impulsivity and aggression in both patient groups. Conclusions: Impairment of FER is present from the first episode of schizophrenia and increases further with multiple psychotic episodes, but it may depend on or contribute to clinical symptoms. Therefore, assessment of FER should be included in the clinical assessment and integrated in the plan of treatment from the beginning of the illness. (JINS, 2019, 25, 165–173)

show abstract

Section: Discussionsupporting

confidence: 87%

Section: Discussionmentioning

confidence: 99%

Differences in Facial Emotional Recognition Between Patients With the First-Episode Psychosis, Multi-episode Schizophrenia, and Healthy Controls

Kuharić¹,

Kekin

Lovrenčić

et al. 2018

J Int Neuropsychol Soc

View full text Add to dashboard Cite

show abstract

“…FAR is among the most researched areas of social cognition in schizophrenia. Systematic reviews of studies investigating psychological interventions targeting FAR have demonstrated that such interventions are efficacious in improving FAR performance and functional status, but not psychotic symptoms [ 57 , 58 ]. For example, a 6-week computerized intervention that included both cognitive training and FAR training was shown to significantly improve FAR and social functioning (assessed using the Personal and Social Performance scale [PSP]) in clinically stable male outpatients with schizophrenia [ 59 ].…”

Section: Core Domains Of Social Cognition In Schizophreniamentioning

confidence: 99%

The Importance of Social Cognition in Improving Functional Outcomes in Schizophrenia

2018

View full text Add to dashboard Cite

Social cognition has become recognized as an important driver of functional outcomes and overall recovery in patients with schizophrenia, mediating the relationship between neurocognition and social functioning. Since antipsychotic therapy targeting remission of clinical symptoms has been shown to have a limited impact on social cognition, there has been an increasing drive to develop therapeutic strategies to specifically improve social cognition in schizophrenia. We sought to review current evidence relating to social cognition in schizophrenia and its clinical implications, including interventions designed to target the core domains of social cognition (emotion processing, theory of mind, attributional bias, and social perception) as a means of improving functional outcomes and thereby increasing the likelihood of recovery. Relevant articles were identified by conducting a literature search in PubMed using the search terms “schizophrenia” AND “cognition” AND “social functioning,” limited to Title/Abstract, over a time period of the past 10 years. Current evidence demonstrates that schizophrenia is associated with impairments in all four core domains of social cognition, during the pre-first-episode, first-episode, early, and chronic phases of the disease, and that such impairments are important determinants of functional outcome. Interventions targeting the four core domains of social cognition comprise psychosocial approaches (social cognition training programs) and pharmacological therapies. Social cognition training programs targeting multiple and specific core domains of social cognition have shown promise in improving social cognition skills, which, in some cases, has translated into improvements in functional outcomes. Use of some psychosocial interventions has additionally resulted in improvements in clinical symptoms and/or quality of life. Pharmacological therapies, including oxytocin and certain antipsychotics, have yielded more mixed results, due in part to the confounding impact of factors including variation in receptor genetics, bioavailability, pharmacokinetics, and drug–drug interactions, and inconsistencies between study designs and medication dosages. Additional research is required to advance our understanding of the role of social cognition in schizophrenia, and to further establish the utility of targeted interventions in this setting.

show abstract

“…Besides, it suggests that the DOP might be helpful for people presenting schizotypal personality traits since participants in the HS group starting in the DOP condition especially benefit from this procedure when recognising disgusted faces, although this effect was not observed with other negative emotions. A recent systematic review (Bordon et al, 2017) suggests that improving the emotional facial expression recognition of patients with schizophrenia may lead to a large gain in social functioning for this group. However, since participants of the present research do not belong to the clinical population, it would be necessary to replicate these findings in patients in order to be sure of the usefulness of this procedure to improve these impairments in different populations, so future studies should explore this issue.…”

Section: Discussionmentioning

confidence: 99%

Differential outcomes, schizotypy, and improvement of the recognition of emotional facial expressions: a preliminary study

González‐Rodríguez

Godoy-Giménez

Cañadas

et al. 2020

Psicológica Journal

View full text Add to dashboard Cite

AbstractSchizotypy is defined as a combination of traits qualitatively similar to those found in schizophrenia, though in a minor severity, that can be found in the nonclinical population. Some studies suggest that people with schizotypal traits have problems recognising emotional facial expressions. In this research, we further explore this issue and we investigate, for the first time, whether the differential outcomes procedure (DOP) may improve the recognition of emotional facial expressions. Participants in our study were students that completed the ESQUIZO-Q-A and were set in two groups, high schizotypy (HS) and low schizotypy (LS). Then, they performed a task in which they had to recognise the emotional facial expression of a set of faces. Participants of the HS group and the LS group did not differ in their performance. Importantly, all participants showed better recognition of emotional facial expressions when they were trained with differential outcomes. This novel finding might be relevant for clinical practice since the DOP is shown as a tool that may improve the recognition of emotional facial expressions.

show abstract

The feasibility and clinical benefits of improving facial affect recognition impairments in schizophrenia: Systematic review and meta-analysis

Cited by 47 publications

References 57 publications

Differences in Facial Emotional Recognition Between Patients With the First-Episode Psychosis, Multi-episode Schizophrenia, and Healthy Controls

Differences in Facial Emotional Recognition Between Patients With the First-Episode Psychosis, Multi-episode Schizophrenia, and Healthy Controls

The Importance of Social Cognition in Improving Functional Outcomes in Schizophrenia

Differential outcomes, schizotypy, and improvement of the recognition of emotional facial expressions: a preliminary study

Contact Info

Product

Resources

About